A First-in-Human Trial of DS3790a in Participants With Hematological Malignancies
Clinical trial NCT07220616 · RECRUITING
Trial details
- NCT number
- NCT07220616
- Sponsor
- Daiichi Sankyo
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-16
- Primary completion
- 2030-11-30
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.